Thu, Dec 25, 2014, 4:28 PM EST - U.S. Markets closed for Christmas


% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • bioimmunomabman bioimmunomabman Dec 2, 2011 8:41 AM Flag

    Negative Fully Priced In

    this is a good post, but a negative outcome/significant delay, or outright rejection is not priced in. AFFY can go a lot lower if rejected and Takeda bails. As AF said, the data look adequate, or similar. The FDA review on Monday will probably look negative, it usually does, so there may be a change to buy lower on Monday morning for those interested. FDA is always a risk, but the efficacy is similar and safety as good in the intended patient population with the portneital for pricing and convenience improvement.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • You know AF is a short shill. He outlines the risks quite well. But I would like to know more about non dialisis patients, there could be an easy explanation for the higher cardiac events. Could be a bad interaction with something else they are on.
      also by AF logic avastin should be raising fda concerns because of the adverse side effects in breast cancer patients. As you know they treat many other indications

0.091+0.0160(+21.33%)Dec 24 12:45 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Yahoo! Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST
Amira Nature Foods Ltd.
NYSEWed, Dec 24, 2014 1:04 PM EST
Virgin America Inc.
NASDAQWed, Dec 24, 2014 1:00 PM EST